He et al. found a significant decrease in OS among NSCLC patients with high HIF-1α plasma levels (>297.7 pg/mL) for patients with SCCs; however, there was no significant difference after stratifying patients by TNM stage [61]. The gene discussed is HIF1A; the disease is non-small cell lung carcinoma.